RecruitingNCT06427408

Longitudinal Study of Gene Expression in the Human Placenta During First-trimester and Full-term Pregnancy at the Single Cell Level

Cellular Transcriptomic Trajectory of the Human Placenta During Pregnancy


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

100 participants

Start Date

Mar 25, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The single nucleus RNA-seq approach allows the placental transcriptome to be analyzed from nuclei, thus preserving the integrity of placental syncytium. This approach is feasible on small fragments of villi and offers for the first time the possibility to consider the characterization of gene expression within the structural unit of the human placenta during pregnancy (at the 1st trimester and childbirth)


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Inclusion Criteria4

  • Age 18 to 50
  • Progressive monofoetal pregnancy between 11 and 15 weeks of amenorrhea
  • Patient with prenatal medical indication and requesting chorionic villus biopsy with cytogenetic analysis or molecular genetics
  • Patient scheduled for delivery at Port-Royal Maternity Hospital

Exclusion Criteria5

  • Minor patient
  • Multiple pregnancy
  • Patient's objection
  • Without health insurance
  • Patient under guardianship or curatorship

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon applicable

Placental transcriptomic analysis


Locations(1)

Maternité Port-Royal, Cochin hospital

Paris, IDF, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06427408


Related Trials